Answers are grounded in this paper and cite their sources.
Background: Whether elevated cytokines and gut metabolites in sepsis and acute kidney injury (AKI) represent upstream contributors or downstream correlates of impaired renal clearance remains unresolved. Aims: To evaluate bidirectional and two-step mediated genetic associations of 21 cytokines and 21 gut metabolites with sepsis and AKI. Study Design: Two-sample bidirectional and exploratory two-step mediation Mendelian randomisation (MR) study (STROBE-MR). Place and Duration of Study: Summary-level analysis of SCALLOP (2023), YFS/FINRISK (2017), CLSA (2023), UK Biobank–FinnGen (2021), and FinnGen R12 (2024; analysed through October 2026). Methodology: GRCh38 instruments (per 1-SD biomarker or log-odds liability; F=20.4–5,240.6) from SCALLOP (N=14,824), YFS/FINRISK (N≤8,293), and CLSA (N=8,299) were tested against overlapping FinnGen R12 AKI (8,383/480,448) and sepsis (17,133/439,048; polygenic P<5×10-6, mean F=23.5) and UKB–FinnGen AKI (7,695/474,571), with MRlap, UKB sepsis, and eGFR-adjusted multivariable MR. Results: Only sepsis-to-AKI survived FDR correction (FinnGen polygenic OR=1.281, 95% CI 1.188–1.380, FDR=2.02×10-10; strict k=3 OR=1.298, 95% CI 0.963–1.751; UKB–FinnGen OR=1.188, 95% CI 1.044–1.352; non-overlapping UKB sepsis OR=1.214, 95% CI 1.068–1.380), exceeding reverse AKI-to-sepsis (Weighted Median OR=1.027). No biomarker survived FDR (BH-FDR=0.162–0.538) or replicated across both AKI datasets. Nominal AKI signals included IL-12B (OR=1.065, 95% CI 1.006–1.127), taurocholenate sulfate (OR=1.089, 95% CI 1.013–1.172), glycochenodeoxycholate 3-sulfate (OR=1.124, 95% CI 1.021–1.238), N-acetylkynurenine (OR=1.062), and butyrylcarnitine (OR=0.958, 95% CI 0.923–0.995); nominal sepsis signals included TRAIL (OR=1.094, 95% CI 1.024–1.168), 6-bromotryptophan (OR=1.091), CCL19 (OR=0.917, 95% CI 0.861–0.977), and cis-IL6R (OR=0.858; uncorrected pind=0.0135–0.0461, BH-FDRind≥0.0828). Uremic toxins, effector cytokines, and 14 reverse models were null. Conclusion: Genetic liability to sepsis is associated with AKI risk, whereas cytokine and gut metabolite signals represent exploratory, nominal leads that do not survive FDR correction.
No takes yet. Share an insight, caveat, or question.
Hernandez et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: